Robuta

https://www.pharmaceutical-technology.com/analyst-comment/jp-morgan-2025-almirall-updates-strategy-with-focus-on-medical-dermatology/ JP Morgan 2025: Almirall updates strategy with focus on medical dermatology - Pharmaceutical... Jan 15, 2025 - In 2023, medical dermatology represented 52% of Almirall's income with a turnover of EUR465.2m ($477.36m). jp morgan 2025